Effects of Triglyceride and Ethyl Ester Forms of EPA on Hepatic Lipid Metabolism in Mice with Non-Alcoholic Fatty Liver Disease

Junli Feng,Shitong Wang,Feifei Chen,Jian Zhang,Qingcheng Wang,Lili Jiang,Zejun Wang,Qing Shen
DOI: https://doi.org/10.1016/j.jff.2024.106179
IF: 5.6
2024-01-01
Journal of Functional Foods
Abstract:In this study, the beneficial effects of EPA in ethyl esters (EE) and triacylglycerides (TAG) forms on high fat diet (HFD)-induced non-alcoholic fatty liver disease (NAFLD) were studied and compared. Results indicated that both EPA-TAG and EPA-EE can alleviate pathological features of NAFLD, such as hepatic lipid accumulation and lobular inflammation, with a more pronounced protective effects observed in EPA-TAG treated mice. The integrated hepatic transcriptomic, metabolic and gut microbiota profiles suggest that EPA-TAG and EPA-EE improved hepatic steatosis by suppression of food intake and lipogenesis, promotion of lipid and phospholipid PUFA remodeling, ketogenesis and fatty acids oxidation, possibly via activating the AMPK/adipocytokine signaling pathway. The protective effect of EPA was also associated with the regulation of intestinal flora structure. In general, EPA-TAG was found to be more effective than EPA-EE in preventing HFD-induced NAFLD by reducing appetite, improving hepatic lipid metabolism, increasing energy expenditure, and enhancing gut-liver cross-talk.
What problem does this paper attempt to address?